Image

Robot-Assisted Tai Chi for Upper Limb Rehabilitation in Stroke Patients

Robot-Assisted Tai Chi for Upper Limb Rehabilitation in Stroke Patients

Recruiting
40-80 years
All
Phase N/A

Powered by AI

Overview

This study aims to compare the effectiveness of Robot-Assisted Tai Chi Training (RATT) versus conventional rehabilitation in improving upper limb motor function post-stroke, and to explore the neuromuscular mechanisms of RATT. Participants will be randomly assigned to one of two groups:

  1. Robot-Assisted Tai Chi Training group: Participants will receive guided Tai Chi arm movements with robotic assistance to enhance coordination and strength.
  2. Conventional rehabilitation group: Participants will perform standard exercises (e.g., stretching, repetitive task practice).

Both groups will receive 60-minute sessions, administered 5 days a week, over 4 weeks. Researchers will measure improvements using clinical scales (e.g., Fugl-Meyer Assessment) and monitor safety.

Eligibility

Inclusion Criteria:

  1. Diagnosed with stroke confirmed by neuroimaging (CT/MRI).
  2. Fugl-Meyer Assessment for Upper Extremity score of 8-44.
  3. First-ever stroke, with unilateral hemiplegia and time since onset ≤12 months.
  4. Aged 40-80 years, regardless of gender.
  5. Voluntarily participated and provided written informed consent. Participants meeting all above criteria were enrolled.

Exclusion Criteria:

  1. Severe cognitive impairment (Montreal Cognitive Assessment score \<10).
  2. Poor sitting balance (\< Grade 2) or inability to maintain seated position for \>60 minutes.
  3. Hypertonia (modified Ashworth Scale score \>2 in affected limb).
  4. Significant hemiplegic shoulder pain (Visual Analogue Scale \>3).
  5. Severe aphasia (Boston Diagnostic Aphasia Examination score \<3).
  6. Severe visual impairment precluding robot-assisted upper limb training.
  7. Moderate-to-severe depression (17-item Hamilton Depression Rating Scale score \>17).
  8. Pre-existing neuromuscular disorders, active malignancies, or uncontrolled systemic diseases (cardiac, renal, hepatic).
  9. Concurrent participation in other clinical trials affecting study outcomes. Participants meeting any of the above criteria were excluded.

Study details
    Stroke

NCT06897631

Jing Tao

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.